Alternatived Products of [ 1202-34-2 ]
Product Details of [ 1202-34-2 ]
CAS No. : 1202-34-2
MDL No. : MFCD00006247
Formula :
C10 H9 N3
Boiling Point :
-
Linear Structure Formula : C5 H4 NNHNH4 C5
InChI Key : HMMPCBAWTWYFLR-UHFFFAOYSA-N
M.W :
171.20
Pubchem ID : 14547
Synonyms :
Chemical Name : Di(pyridin-2-yl)amine
Calculated chemistry of [ 1202-34-2 ] Expand+
Physicochemical Properties
Num. heavy atoms :
13
Num. arom. heavy atoms :
12
Fraction Csp3 :
0.0
Num. rotatable bonds :
2
Num. H-bond acceptors :
2.0
Num. H-bond donors :
1.0
Molar Refractivity :
51.58
TPSA :
37.81 ?2
Pharmacokinetics
GI absorption :
High
BBB permeant :
Yes
P-gp substrate :
No
CYP1A2 inhibitor :
Yes
CYP2C19 inhibitor :
No
CYP2C9 inhibitor :
No
CYP2D6 inhibitor :
No
CYP3A4 inhibitor :
No
Log Kp (skin permeation) :
-5.93 cm/s
Lipophilicity
Log Po/w (iLOGP) :
1.2
Log Po/w (XLOGP3) :
1.99
Log Po/w (WLOGP) :
2.22
Log Po/w (MLOGP) :
0.97
Log Po/w (SILICOS-IT) :
1.71
Consensus Log Po/w :
1.62
Druglikeness
Lipinski :
0.0
Ghose :
None
Veber :
0.0
Egan :
0.0
Muegge :
1.0
Bioavailability Score :
0.55
Water Solubility
Log S (ESOL) :
-2.71
Solubility :
0.337 mg/ml ; 0.00197 mol/l
Class :
Soluble
Log S (Ali) :
-2.41
Solubility :
0.666 mg/ml ; 0.00389 mol/l
Class :
Soluble
Log S (SILICOS-IT) :
-4.21
Solubility :
0.0104 mg/ml ; 0.000061 mol/l
Class :
Moderately soluble
Medicinal Chemistry
PAINS :
0.0 alert
Brenk :
0.0 alert
Leadlikeness :
1.0
Synthetic accessibility :
2.07
Application In Synthesis of [ 1202-34-2 ]
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Downstream synthetic route of [ 1202-34-2 ]
1
[ 5027-32-7 ]
[ 1202-34-2 ]
[ 6147-53-1 ]
(((CH3 CO)2CH)2)4Co4 ((C5 H4 N)2NH)4
[ No CAS ]
3Co(2+) *4CH3 COO(1-) *2(C5 H4 N)2NH(1-) =Co3 (O2 CCH3 )4((C5 H4 N)NH(C5 H4 N))2
[ No CAS ]
2
[ 5027-32-7 ]
[ 1202-34-2 ]
copper(II) trifluoroacetate
[ No CAS ]
[ 245483-57-2 ]
3
[ 5027-32-7 ]
[ 1202-34-2 ]
[ 6147-53-1 ]
[Co(C10 H12 O4 )(2,2'-dipyridylamine)4](CH3 CO2 )2(H2 O)2/CH3 OH
[ No CAS ]
4
[ 1202-34-2 ]
[ 4181-20-8 ]
[ 147970-27-2 ]
5
[ 1202-34-2 ]
cobalt(II) chloride hexahydrate
[ No CAS ]
[ 42835-25-6 ]
C38 H31 CoF2 N5 O6 *H2 O
[ No CAS ]
6
[ 1202-34-2 ]
manganese(II) chloride tetrahydrate
[ No CAS ]
[ 42835-25-6 ]
Mn(flmq)2 (2,2′-bipyridylamine)
[ No CAS ]
Yield Reaction Conditions Operation in experiment
60%
General procedure: The methanolic solution (15mL) containing <strong>[42835-25-6]flumequine</strong> (0.4mmol, 104mg) and KOH (0.4mmol, 22mg) was added, after a 30-min stirring, slowly and simultaneously with a methanolic solution of phen (0.2mmol, 36mg) to a methanolic solution (10mL) of MnCl2·4H2O (0.2mmol, 40mg). The resultant solution was stirred for 15min and left for slow evaporation. Yellow crystals of [Mn(flmq)2(phen)], 2 (98mg, yield: 65%) suitable for X-ray structure determination, were collected after a few days.
Categories